A smartphone’s camera and flashlight features can detect changes in blood flow and identify type 2 diabetes with accuracy comparable to traditional, clinic-based risk scores, new research suggests.
Both initial and serial increases in high-sensitivity C-reactive protein (hsCRP) concentrations are independently predictive of cardiac events following acute coronary syndrome (ACS), according to a new study in JAMA Cardiology.
The proportion of heart attack patients who are 40 or younger has steadily increased over the last decade, according to research set to be presented March 17 at the American College of Cardiology’s scientific sessions in New Orleans.
To conquer STEMI’s “last frontier,” cardiologists are tapping into an evolving arsenal of strategies while calling for more data and standardized definitions to guide treating physicians.
Addressing social determinants of health improves outcomes, possibly providing a return on investment. Margins matter, but it’s a long game, often driven by a sense of mission.
Receiving payments from industry influenced physicians’ device selection but not patient outcomes, according to researchers who analyzed three years of Open Payment Program data.
As new hardware and software are introduced into interventional suites, imaging labs and surgical theaters, who bears responsibility for bringing medical personnel up to speed on the advantages they could deliver for safety and efficacy?
Geisinger is aiming to offer DNA sequencing to all of its 1.5 million patients. Members of its precision health team reveal how the initiative developed and share insights gleaned so far, challenges ahead and questions still to be answered.
Kiran Musunuru, MD, PhD, University of Pennsylvania, Philadelphia
A new stem cell-based test may add certainty to efforts to predict whether so-called variants of uncertain significance will contribute to the development of diseases or be harmless.